Evidence map›Paper›PMID 32754721›Full record

ArticleJVS-vascular science2020

Altered hemodynamics during arteriovenous fistula remodeling leads to reduced fistula patency in female mice.

Tambudzai Kudze, Shun Ono, Arash Fereydooni, Luis Gonzalez, Toshihiko Isaji, Haidi Hu, Bogdan Yatsula, Ryosuke Taniguchi, Jun Koizumi, Toshiya Nishibe and 1 more

Open access · goldAbstract read
In one paragraph

Article in JVS-vascular science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A Vein Attempt? Experimental Models for Arteriovenous Fistula Research.Cardiovascular engineering and technology · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Sustained tenascin-C expression drives neointimal hyperplasia and promotes aortocaval fistula failure.American journal of physiology. Heart and circulatory physiology · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Rebuilding vascular access: from the viewpoint of mechanics and materials.Frontiers in bioengineering and biotechnology · 2024
    Review
  19. The rodent models of arteriovenous fistula.Frontiers in cardiovascular medicine · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Tambudzai KudzeVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven.
Shun OnoDepartment of Diagnostic Radiology, Tokai University School of Medicine, Isehara.
Arash FereydooniVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven.
Luis GonzalezVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven.
Toshihiko IsajiVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven.
Haidi HuVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven.
Bogdan YatsulaVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven.
Ryosuke TaniguchiVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven.
Jun KoizumiDepartment of Diagnostic Radiology, Tokai University School of Medicine, Isehara.
Toshiya NishibeDepartment of Cardiovascular Surgery, Tokyo Medical University, Tokyo.
Alan DardikVascular Biology and Therapeutics Program, Yale School of Medicine, New Haven.
Yale University · USTokai University · JPTokyo Medical University · JP

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
Manipulating the matrix to improve arteriovenous fistula patencyR01HL144476 · NHLBI · YALE UNIVERSITY · PI Alan Dardik · 2019 to 2026
$5.6M
Enhancing venous adaptation to the arterial environmentR01HL128406 · NHLBI · YALE UNIVERSITY · PI DARDIK, ALAN · 2016 to 2019
$1.9M
NHLBI NIH HHS R01 HL128406NHLBI NIH HHS R01 HL144476NIGMS NIH HHS T32 GM007205
6 · The paper itself

Abstract

objectiveThe arteriovenous fistula (AVF) is the preferred method of dialysis access because of its proven superior long-term outcomes.However, women havelower rates of AVF patency andutilizationthan men.We used a novel mouseAVF model that recapitulates human AVF maturation to determine whether there are differences in AVF patency in female and male mice.

methodsAortocaval fistulas were created in female and male C57BL/6 mice (9-10 weeks). At days 0, 3, 7, and 21, infrarenal inferior vena cava (IVC) and aortic diameters and flow velocity were monitored by Doppler ultrasound and used to calculate the vessel diameter, blood flow, and shear stress. AVF were harvested, and expression of proteins was examined by proteomic analysis and immunofluorescence and of messenger RNA by quantitative polymerase chain reaction analysis.

resultsAt baseline, female mice weighed less and had lower IVC velocity and smaller magnitudes of shear stress, but there was no significant difference in IVC diameter and thickness. After AVF creation, both female and male mice had similar IVC dilation and thickening with no significant differences in IVC wall thickness at day 21. However, female mice had diminished AVF patency by day 42 (25.7% vs 64.3%;

conclusionsAVF in female mice have diminished patency, preceded by lower velocity, reduced magnitudes of shear stress, and less laminar flow during remodeling. There is also sex-specific differential expression of proteins involved in thrombosis, response to laminar flow, inflammation, and proliferation. These findings suggest that hemodynamic changes during fistula maturation may play an important role underlying the diminished rates of AVF utilization in women. CLINICAL RELEVANCE: Women have lower rates of arteriovenous fistula (AVF) utilization than men. Using a mouse AVF model that recapitulates human AVF maturation, we show that female mice have similar AVF remodeling but diminished patency. AVF remodeling in female mice is associated with reduced shear stress and laminar flow; lack of increased transcription and translation of several anti-inflammatory, antiproliferative, and laminar flow response proteins (endothelial nitric oxide synthase, Krüppel-like factor 2, and vascular cell adhesion molecule 1); and different patterns of expression of pathways that regulate thrombosis and venous remodeling. Identifying downstream targets involved in these mechanisms may improve AVF outcomes in female patients.

Indexed as

Arteriovenous fistulaFemale sexLaminar flowPatencyShear stress

Identifiers

PMID32754721
PMCPMC7402599
OpenAlexW3012353594

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.